Two disciplines in tandem yield dramatically improved outcomes
There is perhaps no other therapeutic area where interventional approaches have so dramatically changed the outcomes for acute cardiac care patients and in terms of long-term cardiac morbidity and mortality.
Premier Research is among the most experienced CROs in interventional cardiology and, more broadly, in medical devices.
We bring in-depth knowledge of device and pharmaceutical clinical development and the appropriate regulatory pathways. Our integrated, cross-discipline teams understand the unique challenges of study design, statistical planning, and the operational aspects of interventional cardiology development programs.
In addition, patient recruitment for interventional cardiology studies requires knowing and working closely with the appropriate interventional cardiology sites for each study. Over the course of multiple studies, Premier Research has built strong relationships with more than 2,000 investigators and developed a good understanding of each site’s recruitment capabilities. For each study, we carefully select the investigators and study site locations that are best-suited to that study’s particular goals.
Among the cardiovascular devices we have helped develop:
- Ablation systems (RF and ultrasound)
- Atrial fibrillation devices
- Baroreflex stimulators
- Cardiac assist devices
- Cardiac bioprostheses
- Cardiac imaging diagnostics
- Cardiac pressure monitoring devices
- Catheters (laser and drug eluting)
- Drug eluting balloons
- Mechanical reperfusion devices
- Optical coherence tomography devices
- PFO closure devices
- PFO sizer devices
- Pulmonary artery pressure sensors
- Stents (bare metal and drug-eluting)
- Thoracic endoprostheses
- Valve replacements
- Vascular access devices